High materiality7/10
MiniMed price target raised to $28 from $25 at UBS
Why it may matterVerify against the original reporting
upside potential
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raises MMED target to $28 (from $25). Current price is $22.42; priceChangeSinceSignal 5.98.
- UBS raises MMED target to $28; price 22.42
Key facts
- 01
Target: $28
- 02
Posted price: $22.42
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.